iPEPS-ICM
Overview
iPEPS-ICM is the startup accelerator of the Paris Brain Institute (Institut du Cerveau - ICM), focused on supporting the creation and development of companies in biotech, medtech, and digital health related to neuroscience.
Investments
Key People
Lorenzo Posani
Co-Founder
Bizat Nicolas
Principal Investigator
Daniel Racoceanu
Principal Investigator
Isabelle LE BER
Principal Investigator - Research projects on FTD & ALS
Jerome Munuera
INSERM Principal Investigator
Julia Sliwa
SOCIALNEURO Team Leader, CNRS Principal Investigator In Neuroscience
Nicolas Villain
Principal Investigator
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is iPEPS-ICM based?
iPEPS-ICM is headquartered in Paris, France.
When was iPEPS-ICM founded?
iPEPS-ICM was founded in 2012.
How many portfolio companies does iPEPS-ICM have?
iPEPS-ICM has 2 portfolio companies in Caplight's dataset.
What are some companies in iPEPS-ICM's portfolio?
Portfolio companies visible on Caplight include Emobot, Uptale.
What was iPEPS-ICM's most recent investment shown here?
iPEPS-ICM's most recent investment in this portfolio sample was in Emobot in 2025.
What sectors does iPEPS-ICM focus on?
iPEPS-ICM focuses on Enterprise Software, Healthcare & Life Sciences, Enterprise Software, Frontier & Industrial Tech.
What company stages does iPEPS-ICM focus on?
iPEPS-ICM typically invests at the Early stage.